Related Experiment Video
Updated: Jun 13, 2025

07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.3K
Sleep duration and heart failure risk: Insights from a Mendelian Randomization Study
Lianlin Zeng1, Shasha Fu, Hailan Xu
1Department of Rehabilitation Medicine, Suining Central Hospital.
Medicine
|September 17, 2024
Summary
Shorter sleep duration is causally linked to increased heart failure (HF) risk in Europeans. Insomnia also significantly elevates HF risk, underscoring the importance of adequate sleep for cardiovascular health.
Area of Science:
- Cardiovascular Epidemiology
- Genetics
- Sleep Medicine
Background:
- Heart failure (HF) is a major global health concern.
- The causal relationship between sleep duration and HF risk remains incompletely understood.
- Previous studies have shown associations, but causal inference is challenging.
Purpose of the Study:
- To investigate the causal effect of sleep duration on heart failure incidence using a European population.
- To examine the causal impact of insomnia on heart failure risk.
- To leverage genetic data for robust causal inference.
Main Methods:
- Employed a two-sample Mendelian randomization (MR) approach.
- Utilized genome-wide significant single nucleotide polymorphisms (SNPs) associated with continuous sleep duration and insomnia as instrumental variables.
- Analyzed large European cohorts for exposure (sleep duration, insomnia) and outcome (HF) data.
Main Results:
- Genetically inferred shorter sleep duration was causally associated with a reduced risk of heart failure (OR: 0.61, P < .0001).
- Insomnia was causally linked to a significantly increased risk of heart failure (OR: 1.54, P < .02).
- Sensitivity analyses confirmed the robustness of these findings.
Conclusions:
- This study provides evidence for a causal link between sleep duration and heart failure risk in Europeans.
- Shorter sleep duration and insomnia are identified as risk factors for developing heart failure.
- Promoting healthy sleep duration may be a potential strategy for HF prevention.
More Related Videos
Related Concept Videos
Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Longitudinal Studies
142
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
142

